109. M.L. Schipper, Z. Cheng, S.-W. Lee, L.A. Bentolila, G. Iyer, J. Rao et al., microPET-based
biodistribution of quantum dots in living mice. J. Nucl. Med. 48, 1511–1518 (2007)
110. X. Sun, X. Huang, J. Guo, W. Zhu, Y. Ding, G. Niu et al., Self-illuminating
64
Cu-doped
CdSe/ZnS nanocrystals for in vivo tumor imaging. J. Am. Chem. Soc. 136, 1706–1709
(2014)
111. S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of
MAb-targeted Cd
125m Te/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
112. S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of
MAb-targeted Cd
125m Te/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
113. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B.I. Ipe et al., Renal clearance of
quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007)
114. M. Vallet-Regi, A. Rámila, R.P. del Real, J. Pérez-Pariente, A new property of MCM-41:
drug delivery system. Chem. Mater. 13, 308–311 (2001)
115. D.M. Coldwell, A.S. Kennedy, C.W. Nutting, Use of yttrium-90 microspheres in the
treatment of unresectable hepatic metastases from breast cancer. Int. J. Radiat. Oncol. Biol.
Phys. 69, 800–804 (2007)
116. R. Salem, R.J. Lewandowski, B. Atassi, S.C. Gordon, V.L. Gates, O. Barakat et al.,
Treatment of unresectable hepatocellular carcinoma with use of
90
Y microspheres
(TheraSphere): safety, tumor response, and survival. J. Vasc. Interv. Radiol. 16, 1627–
1639 (2005)
117. R.J. Lewandowski, K.G. Thurston, J.E. Goin, C.O. Wong, V.L. Gates, Buskirk M. Van
et al., 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer
metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as
Measured by [18F] Fluorodeoxyglucose positron emission tomography and Computed
Tomographic Imaging. J. Vasc. Interv. Radiol. 16, 1641–1651 (2005)
118. M. Benezra, O. Penate-medina, P.B. Zanzonico, D. Schaer, H. Ow, A. Burns et al.,
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human
melanoma. J. Clin. Invest. 121, 2768–2780 (2011)
119. E. Phillips, O. Penate-Medina, P.B. Zanzonico, R.D. Carvajal, P. Mohan, Y. Ye et al.,
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci.
Transl. Med. 6, 260ra149 (2014)
120. I.I. Slowing, J.L. Vivero-Escoto, C.-W. Wu, Lin VS-Y. Mesoporous silica nanoparticles as
controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60,
1278–1288 (2008)
121. A. Liberman, N. Mendez, W.C. Trogler, A.C. Kummel, Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf. Sci. Rep. 69, 132–158 (2014)
122. K. Zarschler, L. Rocks, N. Licciardello, L. Boselli, E. Polo, K.P. Garcia et al., Ultrasmall
inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
Nanomedicine 12, 1663–1701 (2016)
123. E.B. Ehlerding, F. Chen, W. Cai, Biodegradable and renal clearable inorganic nanoparticles.
Adv. Sci. (Weinh) 3 (2016)
124. J.L. Vivero-Escoto, R.C. Huxford-Phillips, W. Lin, Silica-based nanoprobes for biomedical
imaging and theranostic applications. Chem. Soc. Rev. 41, 2673–2685 (2012)
125. B.G. Trewyn, I.I. Slowing, S. Giri, H.-T. Chen, V.S.-Y. Lin, Synthesis and functionalization
of a mesoporous silica nanoparticle based on the sol-gel process and applications in
controlled release. Acc. Chem. Res. 40, 846–853 (2007)
126. C. Barbé, J. Bartlett, L. Kong, K. Finnie, H.Q. Lin, M. Larkin et al., Silica particles: a novel
drug-delivery system. Adv. Mater. 16, 1959–1966 (2004)
127. R. Kumar, I. Roy, T.Y. Ohulchanskky, L.A. Vathy, E.J. Bergey, M. Sajjad et al., In vivo
biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699–708 (2010)
2 Exogenous Radionanomedicine: Inorganic Nanomaterials
43
biodistribution of quantum dots in living mice. J. Nucl. Med. 48, 1511–1518 (2007)
110. X. Sun, X. Huang, J. Guo, W. Zhu, Y. Ding, G. Niu et al., Self-illuminating
64
Cu-doped
CdSe/ZnS nanocrystals for in vivo tumor imaging. J. Am. Chem. Soc. 136, 1706–1709
(2014)
111. S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of
MAb-targeted Cd
125m Te/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
112. S.J. Kennel, J.D. Woodward, A.J. Rondinone, J. Wall, Y. Huang, S. Mirzadeh, The fate of
MAb-targeted Cd
125m Te/ZnS nanoparticles in vivo. Nucl. Med. Biol. 35, 501–514 (2008)
113. H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B.I. Ipe et al., Renal clearance of
quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007)
114. M. Vallet-Regi, A. Rámila, R.P. del Real, J. Pérez-Pariente, A new property of MCM-41:
drug delivery system. Chem. Mater. 13, 308–311 (2001)
115. D.M. Coldwell, A.S. Kennedy, C.W. Nutting, Use of yttrium-90 microspheres in the
treatment of unresectable hepatic metastases from breast cancer. Int. J. Radiat. Oncol. Biol.
Phys. 69, 800–804 (2007)
116. R. Salem, R.J. Lewandowski, B. Atassi, S.C. Gordon, V.L. Gates, O. Barakat et al.,
Treatment of unresectable hepatocellular carcinoma with use of
90
Y microspheres
(TheraSphere): safety, tumor response, and survival. J. Vasc. Interv. Radiol. 16, 1627–
1639 (2005)
117. R.J. Lewandowski, K.G. Thurston, J.E. Goin, C.O. Wong, V.L. Gates, Buskirk M. Van
et al., 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer
metastases of the liver: Response to treatment at targeted doses of 135–150 Gy as
Measured by [18F] Fluorodeoxyglucose positron emission tomography and Computed
Tomographic Imaging. J. Vasc. Interv. Radiol. 16, 1641–1651 (2005)
118. M. Benezra, O. Penate-medina, P.B. Zanzonico, D. Schaer, H. Ow, A. Burns et al.,
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human
melanoma. J. Clin. Invest. 121, 2768–2780 (2011)
119. E. Phillips, O. Penate-Medina, P.B. Zanzonico, R.D. Carvajal, P. Mohan, Y. Ye et al.,
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci.
Transl. Med. 6, 260ra149 (2014)
120. I.I. Slowing, J.L. Vivero-Escoto, C.-W. Wu, Lin VS-Y. Mesoporous silica nanoparticles as
controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60,
1278–1288 (2008)
121. A. Liberman, N. Mendez, W.C. Trogler, A.C. Kummel, Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf. Sci. Rep. 69, 132–158 (2014)
122. K. Zarschler, L. Rocks, N. Licciardello, L. Boselli, E. Polo, K.P. Garcia et al., Ultrasmall
inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
Nanomedicine 12, 1663–1701 (2016)
123. E.B. Ehlerding, F. Chen, W. Cai, Biodegradable and renal clearable inorganic nanoparticles.
Adv. Sci. (Weinh) 3 (2016)
124. J.L. Vivero-Escoto, R.C. Huxford-Phillips, W. Lin, Silica-based nanoprobes for biomedical
imaging and theranostic applications. Chem. Soc. Rev. 41, 2673–2685 (2012)
125. B.G. Trewyn, I.I. Slowing, S. Giri, H.-T. Chen, V.S.-Y. Lin, Synthesis and functionalization
of a mesoporous silica nanoparticle based on the sol-gel process and applications in
controlled release. Acc. Chem. Res. 40, 846–853 (2007)
126. C. Barbé, J. Bartlett, L. Kong, K. Finnie, H.Q. Lin, M. Larkin et al., Silica particles: a novel
drug-delivery system. Adv. Mater. 16, 1959–1966 (2004)
127. R. Kumar, I. Roy, T.Y. Ohulchanskky, L.A. Vathy, E.J. Bergey, M. Sajjad et al., In vivo
biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4, 699–708 (2010)
2 Exogenous Radionanomedicine: Inorganic Nanomaterials
43